Effect of a single IV infusion of zoledronic acid on bone turnover markers versus oral risedronate in patients with glucocorticoid-induced osteoporosis

被引：0
|
作者：
Sambrook, P.
Devogelaer, J.
Reginster, J.
Saag, K.
Roux, C.
Lau, C.
Papanastasiou, P.
Schoenborn-Kellenberger, O.
Maylandt, K.
Fashola, T.
Mesenbrink, P.
Reid, D.
机构：
[1] Univ Sydney, Sydney, NSW 2006, Australia
[2] Catholic Univ Louvain, B-1200 Brussels, Belgium
[3] Univ Liege, Liege, Belgium
[4] Univ Alabama Birmingham, Birmingham, AL USA
[5] Paris Descartes Univ, Paris, France
[6] Univ Dundee, Dundee, Scotland
[7] Novartis Pharma AG, Basel, Switzerland
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Univ Aberdeen, Aberdeen, Scotland
来源：
BONE | 2009年 / 44卷
关键词：
D O I：
10.1016/j.bone.2009.01.213
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
297
引用
收藏
页码：S94 / S95
页数：2
相关论文
共 50 条
  • [31] Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial
    Reid, David M.
    Devogelaer, Jean-Pierre
    Saag, Kenneth
    Roux, Christian
    Lau, Chak-Sing
    Reginster, Jean-Yves
    Papanastasiou, Philemon
    Ferreira, Alberto
    Hartl, Florian
    Fashola, Taiwo
    Mesenbrink, Peter
    Sambrook, Philip N.
    LANCET, 2009, 373 (9671): : 1253 - 1263
  • [32] EFFECT OF ZOLEDRONIC ACID ON THE BONE TURNOVER MARKERS IN THE PAGET'S DISEASE
    Moro-Alvarez, M. J.
    Serrano, R.
    Espinoza, J.
    Andrade, M.
    de la Piedra, C.
    Diaz-Curiel, M.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 82 - 82
  • [33] Bone turnover markers can be used for monitoring sodium fluoride treatment efficacy in postmenopausal women with glucocorticoid-induced osteoporosis (GIO)
    Daval, AV
    Martchenkova, LA
    Poliakova, EU
    Ernakova, IP
    Milov, NM
    Buzulina, VP
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S58 - S58
  • [34] Modulation of bone turnover by alfacalcidol and/or alendronate does not prevent glucocorticoid-induced osteoporosis in growing minipigs
    Akahoshi, S
    Sakai, A
    Arita, S
    Ikeda, S
    Morishita, Y
    Tsutsumi, H
    Ito, M
    Shiraishi, A
    Nakamura, T
    JOURNAL OF BONE AND MINERAL METABOLISM, 2005, 23 (05) : 341 - 350
  • [35] Parathyroid hormone treatment of women with glucocorticoid-induced osteoporosis dramatically increases bone turnover.
    Lane, NE
    Thompson, JM
    Modin, G
    Pierini, E
    Sanchez, S
    Arnaud, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : 109 - 109
  • [36] TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS WITH STRONTIUM RANELATE: A 2-YEAR OBSERVATIONAL, CONTROLLED STUDY VERSUS RISEDRONATE
    Ringe, J.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 169 - 170
  • [37] TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS WITH STRONTIUM RANELATE: A 2-YEAR OBSERVATIONAL, CONTROLLED STUDY VERSUS RISEDRONATE
    Ringe, J.
    Dorst, A.
    Farahmand, P.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 72 - 72
  • [38] Zoledronic acid-induced hepatotoxicity relieved after subsequent infusions in a Chinese woman with glucocorticoid-induced osteoporosis
    Jiang, Yan
    Fu, Yong
    Xing, Xiao-ping
    Li, Mei
    Wang, Ou
    Xia, Wei-bo
    Meng, Xun-wu
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2015, 20
  • [39] Zoledronic acid-induced hepatotoxicity relieved after subsequent infusions in a Chinese woman with glucocorticoid-induced osteoporosis
    Yan Jiang
    Yong Fu
    Xiao-ping Xing
    Mei Li
    Ou Wang
    Wei-bo Xia
    Xun-wu Meng
    European Journal of Medical Research, 20
  • [40] Modulation of bone turnover by alfacalcidol and/or alendronate does not prevent glucocorticoid-induced osteoporosis in growing minipigs
    Shojiro Akahoshi
    Akinori Sakai
    Shinobu Arita
    Satoshi Ikeda
    Yoshiomi Morishita
    Hideki Tsutsumi
    Masako Ito
    Ayako Shiraishi
    Toshitaka Nakamura
    Journal of Bone and Mineral Metabolism, 2005, 23 : 341 - 350
12345